Next generation gene therapy

Inspired by earlier successes using gene therapy to correct an inherited type of blindness, investigators are poised to extend their approach to other types of blinding disorders. In a new study, researchers compared the safety and efficiency of delivery in an animal model of two different types of vectors. This preclinical work will guide dose-level formulation and type of vector to deliver genes to treat blindness caused by the loss of photoreceptors.

Read the whole article on Science Daily

More from Science Daily